BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37292347)

  • 1. Comparison of video-assisted pleurectomy/decortication surgery plus hyperthermic intrathoracic chemotherapy with VATS talc pleurodesis for the treatment of malignant pleural mesothelioma: A pilot study.
    Migliore M; Fiore M; Filippini T; Tumino R; Sabbioni M; Spatola C; Polosa R; Vigneri P; Nardini M; Castorina S; Basile F; Ferrante M;
    Heliyon; 2023 Jun; 9(6):e16685. PubMed ID: 37292347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma-A Prospective Report.
    Bongiolatti S; Mazzoni F; Salimbene O; Caliman E; Ammatuna C; Comin CE; Antonuzzo L; Voltolini L
    J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleurectomy/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma.
    Klotz LV; Lindner M; Eichhorn ME; Grützner U; Koch I; Winter H; Kauke T; Duell T; Hatz RA
    J Thorac Dis; 2019 May; 11(5):1963-1972. PubMed ID: 31285889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical factors affecting the survival of patients diagnosed with non-small cell lung cancer and metastatic malignant pleural effusion, treated with hyperthermic intrathoracic chemotherapy or chemical talc pleurodesis: a monocentric, prospective, randomized trial.
    Kleontas A; Sioga A; Pandria N; Barbetakis N; Lazopoulos A; Katsikas I; Asteriou C; Paliouras D; Kamperis E; Ikonomou D; Papamitsou T; Filippou D; Destouni C; Ikonomou L; Zarogoulidis K; Papagiannopoulos K
    J Thorac Dis; 2019 May; 11(5):1788-1798. PubMed ID: 31285871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience.
    Migliore M; Calvo D; Criscione A; Palmucci S; Fuccio Sanzà G; Caltabiano R; Spatola C; Privitera G; Aiello MM; Parra HS; Ciancio N; Di Maria G
    Future Oncol; 2015; 11(24 Suppl):19-22. PubMed ID: 26638918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis.
    Zhao ZY; Zhao SS; Ren M; Liu ZL; Li Z; Yang L
    Oncotarget; 2017 Nov; 8(59):100640-100647. PubMed ID: 29246008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermic intrathoracic chemotherapy after extended pleurectomy and decortication for malignant pleura mesothelioma: an observational study on outcome and microcirculatory changes.
    Luzzi L; Franchi F; Dapoto A; Ghisalberti M; Corzani R; Marrelli D; Marchetti L; Paladini P; Scolletta S
    J Thorac Dis; 2018 Jan; 10(Suppl 2):S228-S236. PubMed ID: 29507790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial.
    Rintoul RC; Ritchie AJ; Edwards JG; Waller DA; Coonar AS; Bennett M; Lovato E; Hughes V; Fox-Rushby JA; Sharples LD;
    Lancet; 2014 Sep; 384(9948):1118-27. PubMed ID: 24942631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MesoTRAP: a feasibility study that includes a pilot clinical trial comparing video-assisted thoracoscopic partial pleurectomy decortication with indwelling pleural catheter in patients with trapped lung due to malignant pleural mesothelioma designed to address recruitment and randomisation uncertainties and sample size requirements for a phase III trial.
    Matthews C; Freeman C; Sharples LD; Fox-Rushby J; Tod A; Maskell NA; Edwards JG; Coonar AS; Sivasothy P; Hughes V; Rahman NM; Waller DA; Rintoul RC
    BMJ Open Respir Res; 2019; 6(1):e000368. PubMed ID: 30687504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience.
    Ried M; Potzger T; Braune N; Neu R; Zausig Y; Schalke B; Diez C; Hofmann HS
    Eur J Cardiothorac Surg; 2013 Apr; 43(4):801-7. PubMed ID: 22885228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma.
    Nakas A; Martin Ucar AE; Edwards JG; Waller DA
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):83-8. PubMed ID: 18053737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis.
    Järvinen T; Paajanen J; Ilonen I; Räsänen J
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion.
    Fitzgerald DB; Sidhu C; Budgeon C; Tan AL; Read CA; Kwan BCH; Smith NA; Fysh ET; Muruganandan S; Saghaie T; Shrestha R; Badiei A; Nguyen P; Burke A; Goddard J; Windsor M; McDonald J; Wright G; Czarnecka K; Sivakumar P; Yasufuku K; Feller-Kopman DJ; Maskell NA; Murray K; Lee YCG
    Trials; 2022 Jun; 23(1):530. PubMed ID: 35761341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience.
    Ambrogi MC; Bertoglio P; Aprile V; Chella A; Korasidis S; Fontanini G; Fanucchi O; Lucchi M; Mussi A
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1857-1866.e2. PubMed ID: 29191688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermic Intrathoracic Chemotherapy (HITHOC) for Pleural Malignancies-Experience from Indian Centers.
    Patel MD; Damodaran D; Rangole A; Shaikh S; Shah K; Bagwade R; Bhatt A
    Indian J Surg Oncol; 2019 Feb; 10(Suppl 1):91-98. PubMed ID: 30886500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of pleurectomy-decortication and hyperthermic chemotherapy in mesothelioma.
    Ergönül AG; Aydın S; Kahraman Aydın S; Akçam Tİ; Özdil A; Turhan K; Çakan A; Çağırıcı U
    Turk Gogus Kalp Damar Cerrahisi Derg; 2023 Jul; 31(3):381-387. PubMed ID: 37664769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of survival in patients who underwent video-assisted thoracic surgery talc pleurodesis for malignant pleural effusion.
    Yoon DW; Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM
    Thorac Cancer; 2016 Jul; 7(4):393-8. PubMed ID: 27385980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update in the Treatment of Pleural Tumors: Robotic Surgery Combined with Hyperthermic Intrathoracic Chemotherapy.
    Romano G; Zirafa CC; Ceccarelli I; Elia G; Davini F; Melfi F
    Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of malignant pleural mesothelioma survival after talc pleurodesis or surgery.
    Taioli E; van Gerwen M; Mihalopoulos M; Moskowitz G; Liu B; Flores R
    J Thorac Dis; 2017 Dec; 9(12):5423-5433. PubMed ID: 29312753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does cytoreduction surgery and hyperthermic intrathoracic chemotherapy prolong survival in patients with N0-N1 nonsmall cell lung cancer and malignant pleural effusion?
    Migliore M; Nardini M
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31366459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.